1. Characterization of oncogenic pathways linked with T cell exclusion in urothelial bladder cancer. (4th November 2015) Authors: Sweis, Randy F; Spranger, Stefani; Luke, Jason J; Gajewski, Thomas F Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study. Issue 7 (July 2021) Authors: Lee, Chung-Han; Shah, Amishi Yogesh; Rasco, Drew; Rao, Arpit; Taylor, Matthew H; Di Simone, Christopher; Hsieh, James J; Pinto, Alvaro; Shaffer, David R; Girones Sarrio, Regina; Cohn, Allen Lee; Vogelzang, Nicholas J; Bilen, Mehmet Asim; Gunnestad Ribe, Sara; Goksel, Musaberk; Tennøe, Øyvind Kroh... Journal: Lancet oncology Issue: Volume 22:Issue 7(2021) Page Start: 946 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗